Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Clinical Therapeutics|January 26, 2016
Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy VolunteersStephen A Bai, Qinfang Xiang, Andrew FinnCurrent Medical Research and Opinion|June 5, 2010
Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysisJohn H Peniston, Qinfang Xiang, Errol M GouldThe Journal of Clinical Endocrinology and Metabolism|August 24, 2013
Efficacy and safety of an octreotide implant in the treatment of patients with acromegalyCarla Chieffo, David Cook, Qinfang Xiang, et al.Drug Design, Development and Therapy|December 14, 2011
Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended releaseIrma H Benedek, Janet Jobes, Qinfang Xiang, et al.Advances and Applications in Statistical Sciences|January 1, 2016
Illustrations on Using the Distribution of a P-value in High Dimensional Data AnalysesXiaojun Hu, Gary L Gadbury, Qinfang Xiang, et al.Journal of Pain Research|February 10, 2017
Long-term safety and analgesic efficacy of buprenorphine buccal film in patients with moderate-to-severe chronic pain requiring around-the-clock opioidsMartin Hale, Veronica Urdaneta, M Todd Kirby, et al.Postgraduate Medicine|December 5, 2015
Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back painRichard L Rauck, Jeffrey Potts, Qinfang Xiang, et al.Pain Medicine (Malden, Mass.)|February 27, 2016
Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal BuprenorphineLynn Webster, Daniel Gruener, Todd Kirby, et al.Headache|September 16, 2009
Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruationStephen D Silberstein, Todd Berner, John Tobin, et al.Urology|March 2, 2023
Incremental Treatment Response by Cycle With Collagenase Clostridium Histolyticum for Peyronie's Disease: A Pooled Analysis of Two Phase 3 TrialsMatthew Ziegelmann, Yiqun Hu, Qinfang Xiang, et al.Pageof 3